← All Sponsors
SPONSOR

Universidad Rey Juan Carlos

Total Trials
3
Recruiting
3
Phases
N/A

Universidad Rey Juan Carlos is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Irreversible Pulpitis, Pulpotomy of Permanent Molars, Parkinson' Disease, Multiple Sclerosis.

Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Universidad Rey Juan Carlos

How many clinical trials has Universidad Rey Juan Carlos sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Universidad Rey Juan Carlos, of which 3 are actively recruiting participants. These trials cover conditions including Irreversible Pulpitis, Pulpotomy of Permanent Molars, Parkinson' Disease. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Universidad Rey Juan Carlos research focus on?
Universidad Rey Juan Carlos clinical trials span Irreversible Pulpitis, Pulpotomy of Permanent Molars, Parkinson' Disease, Multiple Sclerosis. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Universidad Rey Juan Carlos clinical trial?
To participate in a Universidad Rey Juan Carlos trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Universidad Rey Juan Carlos trials with current recruitment status updated daily.

Clinical Trials by Universidad Rey Juan Carlos

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology